244 related articles for article (PubMed ID: 27863567)
1. Advancing Precision Nuclear Medicine and Molecular Imaging for Lymphoma.
Wright CL; Maly JJ; Zhang J; Knopp MV
PET Clin; 2017 Jan; 12(1):63-82. PubMed ID: 27863567
[TBL] [Abstract][Full Text] [Related]
2. Molecular Imaging and Precision Medicine in Breast Cancer.
Chudgar AV; Mankoff DA
PET Clin; 2017 Jan; 12(1):39-51. PubMed ID: 27863565
[TBL] [Abstract][Full Text] [Related]
3. Personalized Management Approaches in Lymphoma: Utility of Fluorodeoxyglucose-PET Imaging.
Ayers EC; Fardin S; Gholami S; Alavi A; Mato AR
PET Clin; 2016 Jul; 11(3):209-18. PubMed ID: 27321026
[TBL] [Abstract][Full Text] [Related]
4. Molecular imaging in lymphoma beyond
Kahle XU; Montes de Jesus FM; Glaudemans AWJM; Lub-de Hooge MN; Jorritsma-Smit A; Plattel WJ; van Meerten T; Diepstra A; van den Berg A; Kwee TC; Noordzij W; de Vries EGE; Nijland M
Lancet Haematol; 2020 Jun; 7(6):e479-e489. PubMed ID: 32470439
[TBL] [Abstract][Full Text] [Related]
5. VI. FDG-PET as a biomarker in lymphoma: from qualitative to quantitative analysis.
Meignan M
Hematol Oncol; 2015 Jun; 33 Suppl 1():38-41. PubMed ID: 26062052
[No Abstract] [Full Text] [Related]
6. PET/CT: appropriate application in lymphoma.
Wang X
Chin Clin Oncol; 2015 Mar; 4(1):4. PubMed ID: 25841711
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of therapy for lymphoma.
Jerusalem G; Hustinx R; Beguin Y; Fillet G
Semin Nucl Med; 2005 Jul; 35(3):186-96. PubMed ID: 16098292
[TBL] [Abstract][Full Text] [Related]
8. PET imaging for response assessment in lymphoma: potential and limitations.
Schöder H; Moskowitz C
Radiol Clin North Am; 2008 Mar; 46(2):225-41, viii. PubMed ID: 18619378
[TBL] [Abstract][Full Text] [Related]
9. Molecular Imaging and Precision Medicine: PET/Computed Tomography and Therapy Response Assessment in Oncology.
Sheikhbahaei S; Mena E; Pattanayak P; Taghipour M; Solnes LB; Subramaniam RM
PET Clin; 2017 Jan; 12(1):105-118. PubMed ID: 27863562
[TBL] [Abstract][Full Text] [Related]
10. PET-Derived Quantitative Metrics for Response and Prognosis in Lymphoma.
Kostakoglu L; Chauvie S
PET Clin; 2019 Jul; 14(3):317-329. PubMed ID: 31084772
[TBL] [Abstract][Full Text] [Related]
11. Molecular Imaging and Precision Medicine in Lung Cancer.
Zukotynski KA; Gerbaudo VH
PET Clin; 2017 Jan; 12(1):53-62. PubMed ID: 27863566
[TBL] [Abstract][Full Text] [Related]
12. Critical considerations on the predictive value of end-of-treatment FDG-PET in lymphoma.
Adams HJA; Kwee TC
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):342-343. PubMed ID: 27783106
[No Abstract] [Full Text] [Related]
13. Molecular Imaging and Precision Medicine in Dementia and Movement Disorders.
Mallik AK; Drzezga A; Minoshima S
PET Clin; 2017 Jan; 12(1):119-136. PubMed ID: 27863563
[TBL] [Abstract][Full Text] [Related]
14. Reply to letter of Adams and Kwee: Critical considerations on the predictive value of end-of-treatment FDG/PET in lymphoma.
Fallanca F; Alongi P; Incerti E; Gianolli L; Picchio M; Kayani I; Bomanji JB
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):344-345. PubMed ID: 27796542
[No Abstract] [Full Text] [Related]
15. Imaging: staging and evaluation of lymphoma using nuclear medicine.
Divgi C
Semin Oncol; 2005 Feb; 32(1 Suppl 1):S11-8. PubMed ID: 15786021
[TBL] [Abstract][Full Text] [Related]
16. Measuring the "unmeasurable": assessment of bone marrow response to therapy using FDG-PET in patients with lymphoma.
Goudarzi B; Jacene HA; Wahl RL
Acad Radiol; 2010 Sep; 17(9):1175-85. PubMed ID: 20634105
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET/CT in lymphoma.
Juweid ME
Methods Mol Biol; 2011; 727():1-19. PubMed ID: 21331925
[TBL] [Abstract][Full Text] [Related]
18. Gallium-67 imaging in lymphoma: tricks of the trade.
Morton KA; Jarboe J; Burke EM
J Nucl Med Technol; 2000 Dec; 28(4):221-32. PubMed ID: 11142323
[TBL] [Abstract][Full Text] [Related]
19. The Role of PET/MR Imaging in Precision Medicine.
Huo E; Wilson DM; Eisenmenger L; Hope TA
PET Clin; 2017 Oct; 12(4):489-501. PubMed ID: 28867118
[TBL] [Abstract][Full Text] [Related]
20. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
